πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,720 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6709842

DNA encoding a growth factor specific for epithelial cells

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Mar 23 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 18 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6706873

Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic meth

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Mar 16 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6706754

Reversed amidines and methods of using for treating, preventing, or inhibiting leishmanias

The United States of America as represented by the Secretary of the Army Β· Granted Tue Mar 16 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6703046

Highly cross-linked, extremely hydrophobic nitric oxide-releasing polymers and methods for

The United States of America Β· Granted Tue Mar 09 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 04 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6699842

Dominant negative deletion mutants of C-jun and their use in the prevention and treatment

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Mar 02 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6699835

Formulation of boronic acid compounds

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Mar 02 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6699674

Expression and refolding of truncated recombinant major outer membrane protein antigen (R5

United States of America as represented by the Secretary of the Air Force Β· Granted Tue Mar 02 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6696562

Avian astrovirus

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Feb 24 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6696242

Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic meth

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 24 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6696064

Methods of protecting vasculature from damage by diphtheria toxin-and pseudomonas toxin-ba

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 24 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6692964

Methods for transfecting T cells

United States of America as represented by the Secretary of the Air Force Β· Granted Tue Feb 17 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6689560

Raf protein kinase therapeutics

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 10 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6689383

Chromium-histidine complexes as nutrient supplements

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Feb 10 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6689367

Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleot

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 10 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6686333

Inhibition of HIV replication using soluble Tat peptide analogs

The United States of America as represented by the Department of Health and Human Resources Β· Granted Tue Feb 03 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6685949

Lipooligosaccharide based vaccine for prevention of moraxella (branhamella)catarrhalis inf

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 03 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6685948

Replication-defective dengue viruses that are replication-defective in mosquitoes for use

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 03 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6685944

Modified HCV peptide vaccines

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 03 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6685941

Methods of treating autoimmune disease via CTLA-4Ig

United States of America as represented by the Secretary of the Air Force Β· Granted Tue Feb 03 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6685933

Interferon &agr; hybrids

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 03 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6682758

Water-insoluble drug delivery system

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 27 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6682741

&bgr;2 microglobulin fusion proteins and high affinity variants

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 27 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6682728

Efficient and selective adenoviral-mediated gene transfer into vascular neointima

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 27 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6680374

Invaplex from gram negative bacteria, method of purification and methods of use

The United States of America as represented by the Secretary of the Army Β· Granted Tue Jan 20 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired